Design of immunogens to elicit broadly neutralizing antibodies against HIV targeting the CD4 binding site
- 2 March 2021
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 118 (9)
- https://doi.org/10.1073/pnas.2018338118
Abstract
A vaccine which is effective against the HIV virus is considered to be the best solution to the ongoing global HIV/AIDS epidemic. In the past thirty years, numerous attempts to develop an effective vaccine have been made with little or no success, due, in large part, to the high mutability of the virus. More recent studies showed that a vaccine able to elicit broadly neutralizing antibodies (bnAbs), that is, antibodies that can neutralize a high fraction of global virus variants, has promise to protect against HIV. Such a vaccine has been proposed to involve at least three separate stages: First, activate the appropriate precursor B cells; second, shepherd affinity maturation along pathways toward bnAbs; and, third, polish the Ab response to bind with high affinity to diverse HIV envelopes (Env). This final stage may require immunization with a mixture of Envs. In this paper, we set up a framework based on theory and modeling to design optimal panels of antigens to use in such a mixture. The designed antigens are characterized experimentally and are shown to be stable and to be recognized by known HIV antibodies.This publication has 52 references indexed in Scilit:
- A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing AntibodiesPLoS Pathogens, 2013
- Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginningNature Reviews Immunology, 2013
- Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibodyProceedings of the National Academy of Sciences of the United States of America, 2013
- Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 BindingScience, 2011
- Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01Science, 2010
- Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeysNature Medicine, 2010
- T-Cell Vaccine Strategies for Human Immunodeficiency Virus, the Virus with a Thousand FacesJournal of Virology, 2009
- Broad HIV-1 neutralization mediated by CD4-binding site antibodiesNature Medicine, 2007
- The Protein Data BankNucleic Acids Research, 2000
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993